NCT01529294View on ClinicalTrials.gov

Single-dose Iloperidone Pharmacokinetics in Patients With Mild or Moderate Liver Disease, Compared to Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

90

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions

Hepatic Impairment

Interventions

DRUG

Iloperidone

Trial Locations (4)

32809

Novartis Investigative Site, Orlando

33143

Novartis Investigative Site, South Miami

33169

Novartis Investigative Site, Miami

92801

Novartis Investigative Site, Anaheim

Sponsors

Lead Sponsor

Novartis Pharmaceuticals

All Listed Sponsors

lead

Novartis Pharmaceuticals

INDUSTRY